Applied Health Economics and Health Policy

Article	Citations
The Danish EQ-5D-5L Value Set: A Hybrid Model Using cTTO and DCE Data	91
Willingness to Pay for a COVID-19 Vaccine	89
The Role of Mental Health on Workplace Productivity: A Critical Review of the Literature	41
Disease-Specific Out-of-Pocket Payments, Catastrophic Health Expenditure and Impoverishment Effects in India: An Analysis of National Health Survey Data	33
Analysing the Efficiency of Health Systems: A Systematic Review of the Literature	32
Health Financing in Sub-Saharan Africa: From Analytical Frameworks to Empirical Evaluation	31
Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward	30
How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness? A Cost-effectiveness Analysis for COVID-19 in Germany	29
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland	28
The Effects of School Closures on COVID-19: A Cross-Country Panel Analysis	28
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options	27
Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America	25
Population Norms for SF-6Dv2 and EQ-5D-5L in China	22
Costs of Illness of Spinal Muscular Atrophy: A Systematic Review	21
The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review	21
The Sandbox Approach and its Potential for Use in Health Technology Assessment: A Literature Review	20
Translating Research to Policy: Setting Provider Payment Rates for Strategic Purchasing under India's National Publicly Financed Health Insurance Scheme	20
COVID-19 Vaccine Demand and Financial Incentives	20
How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/13	20
‘What You See is All There is’: The Importance of Heuristics in Cost-Benefit Analysis (CBA) and Social Return on Investment (SROI) in the Evaluation of Public Health Interventions	19
Does Biosimilar Bevacizumab Offer Affordable Treatment Options for Cancer Patients in the USA? A Budget Impact Analysis from US Commercial and Medicare Payer Perspectives	19
Incidence of Catastrophic Health Expenditure and Its Determinants in Cancer Patients: A Systematic Review and Meta-analysis	19
Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines	17
Family Spillover Effects: Are Economic Evaluations Misrepresenting the Value of Healthcare Interventions to Society?	17
The Health and Productivity Burden of Depression in South Korea	15

EQ-5D-5L Health-State Values for the Mexican Population	15
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy	14
Which Criteria are Considered and How are They Evaluated in Health Technology Assessments? A Review of Methodological Guidelines Used in Western and Asian Countries	14
Economic Evaluations of Preventive Interventions for Dental Caries and Periodontitis: A Systematic Review	13
Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy	13
Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom	13
Cost-effectiveness of Interventions for Chronic Fatigue Syndrome or Myalgic Encephalomyelitis: A Systematic Review of Economic Evaluations	12
National Methodological Guidelines to Conduct Budget Impact Analysis for Health Technology Assessment in India	12
Methodological Note: Reporting Deterministic versus Probabilistic Results of Markov, Partitioned Survival and Other Non-Linear Models	12
Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends	12
EQ-5D-5L Population Norms for Italy	12
Centralised Pharmaceutical Procurement: Learnings from Six European Countries	11
Systematic Review of the Psychometric Performance of Generic Childhood Multi-attribute Utility Instruments	11
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations	11
Korean Guidelines for Pharmacoeconomic Evaluations: Updates in the Third Version	11
Cost Effectiveness of Case Detection Strategies for the Early Detection of COPD	11
The Impact of Financing Health Services on Income Inequality in an Unequal Society: The Case of South Africa	10
Effect of Competition on Generic Drug Prices	10
Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere?	10
Approaches to Measure Efficiency in Primary Care: A Systematic Literature Review	10
Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment	10
Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?	10
Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government	9
Development of an Instrument for the Assessment of Health-Related Multi-sectoral Resource Use in Europe: The PECUNIA RUM	9
Consumers' Preferences and Willingness to Pay for Personalised Nutrition	9
Can the UK ‘Netflix’ Payment Model Boost the Antibacterial Pipeline?	9
Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations	8
Information Asymmetry in Hospitals: Evidence of the Lack of Cost Awareness in Clinicians	8
Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER Study	8
Systematic Literature Review of Guidelines on Budget Impact Analysis for Health Technology Assessment	8
Global Pull Incentives for Better Antibacterials: The UK Leads the Way	7
The Cost Effectiveness of Taxation of Sugary Foods and Beverages: A Systematic Review of Economic Evaluations	7
Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies	7
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon	7
Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway: A Decision Tree Approach	7
What Policy Approaches Were Effective in Reducing Catastrophic Health Expenditure? A Systematic Review of Studies from Multiple Countries	6
UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update	6
Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries	6
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach	6
Cost Effectiveness of Pharmacological Management for Osteoarthritis: A Systematic Review	6
Authors’ Reply to Sprengholz and Betsch: “Willingness to Pay for a COVID-19 Vaccine”	6
Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries	6
Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women	6
Cost-Effectiveness Analysis of Oral Direct-Acting Antivirals for Chinese Patients with Chronic Hepatitis C	6
What Features of Fertility Treatment do Patients Value? Price Elasticity and Willingness-to-Pay Values from a Discrete Choice Experiment	6
myCOPD App for Managing Chronic Obstructive Pulmonary Disease: A NICE Medical Technology Guidance for a Digital Health Technology	6
Pricing and Reimbursement of Patent-Protected Medicines: Challenges and Lessons from South-Eastern Europe	6
Preferred Attributes of Care Pathways for Obstructive Sleep Apnoea from the Perspective of Diagnosed Patients and High-Risk Individuals: A Discrete Choice Experiment	6
Prescription Drug Monitoring Programs and Opioid Prescriptions for Disability Conditions	6
Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance	6

How Responsive is Mortality to Locally Administered Healthcare Expenditure? Estimates for England for 2014/15	6
Opioid Prescribing in Canada following the Legalization of Cannabis: A Clinical and Economic Time-Series Analysis	6
Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis	6
Cost‑Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung Cancer in Sweden	6
How Much Money Should be Paid for a Patient to Isolate During the COVID-19 Outbreak? A Discrete Choice Experiment in Iran	5
Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers	5
A Review of Web-Based Tools for Value-of-Information Analysis	5
Evaluating Health Inequality in Five Caribbean Basin Countries Using EQ-5D-5L	5
Productivity Loss and Indirect Costs for Patients Newly Diagnosed with Early- versus Late-Stage Cancer in the USA: A Large-Scale Observational Research Study	5
Economic Evaluation of an Intervention Designed to Reduce Bullying in Australian Schools	5
Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?	5
Correction to: Translating Research to Policy: Setting Provider Payment Rates for Strategic Purchasing under India’s National Publicly Financed Health Insurance Scheme	5
Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines	5
Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis	5
A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks	5
Budget Impact Analysis of the Introduction of Subcutaneous Infliximab (CT-P13 SC) for the Treatment of Rheumatoid Arthritis in the United Kingdom	5
Towards a New Understanding of Unmet Medical Need	5
Costs and Cost-Effectiveness of User-Testing of Health Professionals’ Guidelines to Reduce the Frequency of Intravenous Medicines Administration Errors by Nurses in the United Kingdom: A Probabilistic	5
Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China	5
Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis	5
Cost-Effectiveness and Value of Information Analysis of an Ambient Intelligent Geriatric Management (AmbIGeM) System Compared to Usual Care to Prevent Falls in Older People in Hospitals	4
Health Inequalities: To What Extent are Decision-Makers and Economic Evaluations on the Same Page? An English Case Study	4
How to Cost the Implementation of Major System Change for Economic Evaluations: Case Study Using Reconfigurations of Specialist Cancer Surgery in Part of London, England	4
Is There Broad-Based Support in High-Income Countries for COVID-19 Vaccine Donation? Evidence from Seven Countries	4
Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older	4
Elections have Consequences: Partisan Politics may be Literally Killing Us	4
Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line Setting	4
Exploring Consumer Preferences for Cannabis Vaping Products to Support Public Health Policy: A Discrete Choice Experiment	4
A Systematic Review of Kidney Transplantation Decision Modelling Studies	4
Willingness to Pay for National Health Insurance: A Contingent Valuation Study Among Patients Visiting Public Hospitals in Melaka, Malaysia	4
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany	4
Integrated Care in Europe: Time to Get it Together?	4
Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores	4
The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022	4
Exploring EQ-5D-Y-3L Experience-Based VAS Values Derived Among Adolescents	4
The Effect of Price Changes and Teaspoon Labelling on Intention to Purchase Sugar-Sweetened Beverages: A Discrete Choice Experiment	4
Comment on: “Willingness to Pay for a COVID-19 Vaccine”	4
Child–Parent Agreement in the Assessment of Health-Related Quality of Life Using the CHU9D and the PedsQLTM	3
The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework	3
Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand	3
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis	3
Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040	3
Stakeholder Engagement in the Development of Public Health Economic Models: An Application to Modelling of Minimum Unit Pricing of Alcohol in South Africa	3
What About Offering a Financial Incentive Directly to Clinical Units to Encourage the Use of Biosimilars? Results of a Two-Year National Experiment in France	3
Scope Issue in Contingent Valuation Studies of the COVID-19 Vaccine: The Case of China	3
The Economic Cost of Rising Non-communicable Diseases in India: A Systematic Literature Review of Methods and Estimates	3
Is Using Sodium-Glucose Cotransporter-2 Inhibitors to Treat Adults with Chronic Heart Failure Cost-Effective? A Systematic Review of Cost-Effectiveness Studies	3
Population-Based Testing for Undiagnosed Hepatitis C: A Systematic Review of Economic Evaluations	3
A Guideline-Implementation Intervention to Improve the Management of Low Back Pain in Primary Care: A Difference-in-Difference-in-Differences Analysis	3
Developing a Framework for the Health Technology Assessment of Histology-independent Precision Oncology Therapies	3
Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies Guidance	3
Health Economics in a World of Uneconomic Growth	3
Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study	3
Economic Evaluation of Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate for the Treatment of Moderate to Very Severe Chronic Obstructive Pulmonary Disease in China Using a Semi-Markov	3
A Systematic Review on Economic Evaluation Studies of Diagnostic and Therapeutic Interventions in the Middle East and North Africa	3
Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn’s Disease	3
Measurement of Health-Related Quality of Life from Conception to Postpartum Using the EQ-5D-5L Among a National Sample of US Pregnant and Postpartum Adults	3
Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi	3
What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death Approaches	3
Are Medical Devices Cost-Effective?	3
From Spreadsheets to Script: Experiences From Converting a Scottish Cardiovascular Disease Policy Model into R	3
How Far is Germany From Value-Based Pricing 10 Years After the Introduction of AMNOG?	3
Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients	2
Cost-effectiveness Analysis of the Dental RECUR Pragmatic Randomized Controlled Trial: Evaluating a Goal-oriented Talking Intervention to Prevent Reoccurrence of Dental Caries in Children	2
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?	2
The Value of New: Consideration of Product Novelty in Health Technology Assessments of Pharmaceuticals	2
Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions	2
Incorporating Process Utility into Cost-Effectiveness Analysis via a Bolt-On Domain to the SF-6D: An Exploratory Study	2
A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?	2
An Economic Model for Estimating Trial Costs with an Application to Placebo Surgery Trials	2
How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts	2
Health Service Utilisation of People Living with Psychosis: Validity of Self-report Compared with Administrative Data in a Randomised Controlled Trial	2
Methods for Economic Evaluations of Novel Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review	2
Cost of Low-Value Imaging Worldwide: A Systematic Review	2
Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L	2
Headroom Analysis for Early Economic Evaluation: A Systematic Review	2
The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil	2
Episcissors-60 for Mediolateral Episiotomy: Evaluation of Clinical and Economic Evidence to Inform NICE Medical Technologies Guidance	2
Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand	2
A Comparative Analysis of Anticancer Drug Appraisals Including Managed Entry Agreements in South Korea and England	2

Data-Related Challenges in Cost-Effectiveness Analyses of Vaccines	2
Financial Incentives in the Path to Recovery from the COVID-19 Pandemic	2
Participatory Value Evaluation (PVE): A New Preference-Elicitation Method for Decision Making in Healthcare	2
The Impact of Value-Based Payment Models for Networks of Care and Transmural Care: A Systematic Literature Review	2
Determinants of COVID-19 Vaccine Rollouts and Their Effects on Health Outcomes	2
The Cost-Effectiveness of Adjunctive Lifestyle Interventions for the Management of Cancer: A Systematic Review	2
Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit	2
Population-Level Impact of Omitting Axillary Lymph Node Dissection in Early Breast Cancer Women: Evidence from an Economic Evaluation in Germany	2
ENTIMOS: A Discrete Event Simulation Model for Maximising Efficiency of Infusion Suites in Centres Treating Multiple Sclerosis Patients	2
Budget Impact Analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring System® in Patients with Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus with Multiple Daily Insulin Injections	2
Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting	2
Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models	2
Economic Analyses of Pathogen-Reduction Technologies in Blood Transfusion: A Systematic Literature Review	2
The Vatican City State Internal Healthcare System Response to COVID-19 Pandemic: Prevention and Control Strategies	2
Modelling Informal Carers’ Health-Related Quality of Life: Challenges for Economic Evaluation	2
Cost-Effectiveness and Value of Information of Cabozantinib Treatment for Patients with Advanced Renal Cell Carcinoma After Failure of Prior Therapy in South Korea	2